Go Pro
NASDAQ:IDXX

IDEXX Laboratories Q2 2026 Earnings Report

IDEXX Laboratories logo
$556.20 +11.88 (+2.18%)
Closing price 04:00 PM Eastern
Extended Trading
$555.62 -0.58 (-0.10%)
As of 07:34 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

IDEXX Laboratories EPS Results

Actual EPS
N/A
Consensus EPS
$3.95
Beat/Miss
N/A
One Year Ago EPS
N/A

IDEXX Laboratories Revenue Results

Actual Revenue
N/A
Expected Revenue
$1.20 billion
Beat/Miss
N/A
YoY Revenue Growth
N/A

IDEXX Laboratories Announcement Details

Quarter
Q2 2026
Time
Before Market Opens
Conference Call Date
Tuesday, August 4, 2026
Conference Call Time
8:30AM ET

Conference Call Resources

IDEXX Laboratories Earnings Headlines

SPCX Warning - and Worst News for Stocks in 50 Years
Goldman Sachs and Morgan Stanley are now predicting what could be the worst news for the U.S. stock market in 50 years - and it has nothing to do with a single stock. According to multiple Wall Street banks, a coming crisis could keep your portfolio in the red for 10 years or longer. Keith Kaplan, CEO of TradeSmith, is sharing what you can do to protect your wealth before it hits.tc pixel
See More IDEXX Laboratories Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like IDEXX Laboratories? Sign up for Earnings360's daily newsletter to receive timely earnings updates on IDEXX Laboratories and other key companies, straight to your email.

About IDEXX Laboratories

IDEXX Laboratories (NASDAQ:IDXX) (NASDAQ: IDXX) is a global developer, manufacturer and provider of diagnostic products and services primarily for the animal health, water testing and food safety markets. Headquartered in Westbrook, Maine, the company supplies in-clinic diagnostic instruments, consumables, reference laboratory testing and practice-management tools that support veterinarians, livestock and dairy producers, and utilities and food producers worldwide.

IDEXX’s product portfolio includes point-of-care tests and immunoassays designed for rapid diagnosis in veterinary clinics, in-clinic chemistry and hematology analyzers, automated urinalysis systems, and digital diagnostic solutions. The company also operates commercial reference laboratories that provide routine and specialty testing, and offers software and connectivity platforms that deliver laboratory results, imaging and practice-management functionality to veterinary practices. In addition to companion animal diagnostics, IDEXX provides testing and monitoring solutions for dairy herd management, livestock health and water quality.

Founded in the early 1980s and based in Maine, IDEXX has grown into a multinational business with operations and customers across North America, Europe, the Asia-Pacific region and Latin America. Its customer base spans independent and corporate veterinary practices, academic and research institutions, municipal and industrial water utilities, and participants in the food supply chain. The company emphasizes recurring revenue streams from consumables and laboratory services alongside instrument sales, supported by ongoing research and development efforts to expand diagnostic capabilities and digital offerings.

IDEXX positions itself as a technology-driven diagnostics company focused on improving decision-making for animal and public health. Its strategy centers on broadening its diagnostic menu, strengthening laboratory and digital service offerings, and supporting veterinary and public health customers with integrated solutions that aim to improve clinical outcomes and operational efficiency.

View IDEXX Laboratories Profile